Page 25 - 202007
P. 25
hepatocarcinoma HepG2 cells through the NF-κB p65 and oxidative stress inhibitory effects of ethanol extracts
pathway[J]. Acta Pharmacologica Sinica,2017,38(4): from Cornus officinalis on raw 264.7 cells[J]. BMC Com-
524-538. plem Altern M,2016.DOI:10.1186/s12906-016-1172-3.
[ 2 ] ARE C,MEYER B,STACK A,et al. Global trends in the [17] HUANG J,ZHANG Y,DONG L,et al. Ethnopharmacolo-
burden of liver cancer[J]. J Surg Oncol,2017,115(5): gy,phytochemistry,and pharmacology of cornus officina-
591-602. lis sieb. et zucc[J]. J Ethnopharmacol,2018.DOI:10.1016/
[ 3 ] ZHOU J,SUN H,WANG Z,et al. Guidelines for diagno- j.jep.2017.11.010.
sis and treatment of primary liver cancer in China:2017 [18] 党文军.马钱苷抑制人恶性黑色素瘤A375细胞的作用及
edition[J]. Liver Cancer,2018,7(3):235-260. 机制研究[D].哈尔滨:黑龙江中医药大学,2016.
[ 4 ] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Glob- [19] 胡小红,王美玲,谌江城,等.马钱苷对结肠癌 SW480 细
al cancer statistics 2018:GLOBOCAN estimates of inci- 胞增殖的影响及机制初探[J].广东药学院学报,2015,31
dence and mortality worldwide for 36 cancers in 185 coun- (1):80-83.
tries[J]. CA Cancer J Clin,2018,68(6):394-424. [20] HOSSEINPOUR-JAGHDANI F,SHOMALI T,GHOLI-
[ 5 ] WANG F,FAN J,ZHANG Z,et al. The global burden of POUR-SHAHRAKI S,et al. Cornus mas:a review on tra-
liver disease:the major impact of China[J]. Hepatology, ditional uses and pharmacological properties[J]. J Comple-
2014,60(6):2099-2108. ment Integr Med,2017.DOI:10.1515/jcim-2016-0137.
[ 6 ] FU J,WANG H. Precision diagnosis and treatment of liver [21] 赵建龙,李世朋.山茱萸果核醇提取物诱导肝癌细胞
cancer in China[J]. Cancer Letters,2018.DOI:10.1016/j. HepG2 凋亡的研究[J].中国临床药理学杂志,2015,31
canlet.2017.10.008 . (13):1276-1278.
[ 7 ] HIROKAWA F,HAYASHI M,ASAKUMA M,et al. Risk [22] 胡小红,王美玲,谌江城,等.马钱苷对结肠癌 SW480 细
factors and patterns of early recurrence after curative hepa- 胞增殖的影响及机制初探[J].广东药学院学报,2015,31
tectomy for hepatocellular carcinoma[J]. Surg Oncol, (1):80-83.
2016,25(1):24-29. [23] FU J,WANG H. Precision diagnosis and treatment of liver
[ 8 ] SANTONI M,CONTI A,DE GIORGI U,et al. Risk of cancer in China[J]. Cancer Letters,2018.DOI:10.1016/j.
gastrointestinal events with sorafenib,sunitinib and pazo- canlet.2017.10.008.
panib in patients with solid tumors:a systematic review [24] DELLA CORTE C,TRIOLO M,IAVARONE M,et al.
and meta-analysis of clinical trials[J]. Int J Cancer,2014, Early diagnosis of liver cancer:an appraisal of internation-
135(4):763-773. al recommendations and future perspectives[J]. Liver In-
[ 9 ] RANDRUP HC,GRIMM D,BAUER J,et al. Effects and ternational,2016,36(2):166-176.
side effects of using sorafenib and sunitinib in the treat- [25] KHAN M,GARG A,SRIVASTAVA SK,et al. A cytotoxic
ment of metastatic renal cell carcinoma[J]. Int J Mol Sci, agent from Strychnos nux-vomica and biological evalua-
2017.DOI:10.3390/ijms18020461. tion of its modified analogues[J]. Med Chem Res,2012,21
[10] 陈吉炎,王雪芹,安志斌,等.武当山地区道地药材的发展 (10):2975-2980.
模式研究[J].中国药房,2011,22(43):4123-4125. [26] QIE S,DIEHL JA. Cyclin D1,cancer progression,and op-
[11] 冀麟麟,王欣,钟祥健,等.山茱萸的化学成分及其抗氧化 portunities in cancer treatment[J]. J Mol Med,2016,94
活性[J].现代食品科技,2019,35(5):137-143. (12):1313-1326.
[12] 叶贤胜,赫军,张佳琳,等.山茱萸的化学成分研究[J].中 [27] 林宇静,郭瑞珍,王海青.细胞周期调控系统相关因子
国中药杂志,2016,41(24):4605-4609. Cyclin D1-CDK4-p21在瘢痕癌中的表达及意义[J].医学
[13] 雷小小,苏艳莹,李美云,等.山茱萸环烯醚萜苷中马钱苷 研究生学报,2014,27(9):923-927.
和莫诺苷的研究进展[J].上海中医药杂志,2018,52(1): [28] QIU Z,ZHANG C,ZHOU J,et al. Celecoxib alleviates
104-108. AKT/c-Met-triggered rapid hepatocarcinogenesis by sup-
[14] HE K,SONG S,ZOU Z,et al. The hypoglycemic and syn- pressing a novel COX-2/AKT/FASN cascade[J]. Mol Car-
ergistic effect of loganin,morroniside,and ursolic acid iso- cinog,2019,58(1):31-41.
lated from the fruits of cornus officinalis[J]. Phytother [29] BURANDT E,GRUENERT M,LEBEAU A,et al. Cyclin
Res,2016,30(2):283-291. D1 gene amplification is highly homogeneous in breast
[15] KIM MJ,BAE GS,JO IJ,et al. Loganin protects against cancer[J]. Breast Cancer,2016,23(1):111-119.
pancreatitis by inhibiting NF-kappaB activation[J]. Eur J [30] JURIKOVA M,DANIHEL L,POLAK S,et al. Ki67,PC-
Pharmacol,2015.DOI:10.1016/j.ejphar.2015.09.019. NA,and MCM proteins:markers of proliferation in the di-
[16] HWANG K,HWANG Y,SONG J. Antioxidant activities agnosis of breast cancer[J]. Acta Histochemica,2016,118
中国药房 2020年第31卷第7期 China Pharmacy 2020 Vol. 31 No. 7 ·787 ·